Contact information
E-mail: yulyashternis@yandex.ru
Phone: 89609268013
Brief biography
In 2025, she graduated from the Siberian State Medical University (SibSMU) with a degree in Medical Biochemistry. She was awarded a diploma with honors and a gold medal "For excellent graduation". He has been working at the Research Institute of Mental Health since 2024.
Field of scientific interest
Biochemical and molecular‑genetic mechanisms of mental disorders, schizophrenia, predictors of suicidal behavior..
Achievements, awards, grants:
Y.V. Shternis is the Laureate of the 1st degree in the competition for young scientists and specialists “Scientific Potential of Tomsk Psychiatry” (February 2025, Tomsk).
Laureate of the 2nd degree at the All‑Russian Student Scientific Conference named after N. I. Pirogov with international participation (April 2025, Tomsk);
Laureate of the 2nd degree in the competition of poster presentations by young scientists at the 7th Kostroma School of Young Scientists in the Field of Mental Health “Psychiatry as a Calling: from Academic Tradition to Modern Challenges,” dedicated to the 95th anniversary of Academician A. S. Tiganov (October 2026, Kostroma).
Laureate of the 1st degree in the competition of poster presentations by young scientists at the anniversary scientific and practical conference with international participation “Current Issues in Psychiatry and Narcology,” dedicated to the 45th anniversary of the Research Institute of Mental Health and the 135th anniversary of the Department of Psychiatry, Narcology and Psychotherapy at SibSMU (October 2026).
Y.V. Shternis was a participant in the following projects:
1. RNF grant No. 23-75-10088 “The role of antioxidant enzymes and nitric oxide synthases in the mechanisms of metabolic syndrome development in schizophrenia.” 2023-2026.
2. RNF grant No. 25-15-00344 “Constitutional and biological predictors of the risk of suicidal behavior in patients with schizophrenia.” 2025-2027.
3. RNF grant No. 26-75-10072 “The role of ferroptosis processes in the clinical phenotype of schizophrenia.” 2026-2029.
Key publications:
Y.V. Shternis is the author (co‑author) of 10 publications in central and regional journals (including abstracts and conference materials), 1 certificate of database registration, and 1 invention patent.
1. Mednova, I. A., Shternis, Y. V., Kornetova, E. G., Bokhan, N. A., & Ivanova, S. A. (2026). Glutathione antioxidant pathways in patients with schizophrenia: relationship with metabolic syndrome. The World Journal of Biological Psychiatry, 1–9. https://doi.org/10.1080/15622975.2026.2613246
2. Shternis Yu.V., Mednova I.A., Petkun D.A., Kornetova E.G., Ivanova S.A. Serum concentration of NOS1AP: association with clinical polymorphism of schizophrenia and metabolic syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(3):167–173. https://doi.org/10.17116/jnevro2026126031167 (In Russ)
3. Shternis, Y.V., Mednova, I.A., Petkun, D.A. et al. Serum NOS1AP Concentration: Association with Clinical Polymorphism of Schizophrenia and Metabolic Syndrome. Neurosci Behav Physi 56, 1158–1163 (2026). https://doi.org/10.1007/s11055-026-02062-4
4. Mednova I.A., Shternis Yu.V., Kornetova E.G., Kornetov A.N., Agarkov A.A., Bokhan N.A., Ivanova S.A. The relationship between CRP and chitinase‑3‑like protein 1 and suicidal behavior, as well as anxiety and depressive symptoms in patients with schizophrenia. Suicidology. 2026; 17 (3): 86-101. doi.org/10.32878/suiciderus.26-17-03(64)-86-101 5. (In Russ)
5. Shternis Yu.V., Petkun D.A., Mednova I.A. The role of oxidative stress and the antioxidant defense system in the development of metabolic syndrome in patients with schizophrenia. Psychiatry. Volume 24. No 4S. 2026. doi: 10.30629/2618-6667-2026-24-4-2 (In Russ)